Table 5 Antibiotic susceptibility profiles of isolated LAB.

From: Potential probiotic Lactobacillus delbrueckii subsp. lactis KUMS-Y33 suppresses adipogenesis and promotes osteogenesis in human adipose-derived mesenchymal stem cell

Isolated strains

Antibiotics susceptibility zone of inhibition (mm)

V

S

K

TE

E

AM

CC

C

CN

GM

Y12

0.00 ± 0.00c

18.00 ± 0.71d

0.00 ± 0.00e

16.67 ± 0.41c

14.67 ± 0.82c

11.67 ± 1.02d

14.00 ± 0.51b

17.00 ± 0.64c

0.00 ± 0.00e

08.67 ± 1.06c

Y17

6.33 ± 0.21b

20.00 ± 1.02bc

16.33 ± 0.32b

0.00 ± 0.00d

18.33 ± 0.64b

16.67 ± 0.94c

22.00 ± 0.61a

16.33 ± 0.75c

14.33 ± 0.52c

10.67 ± 1.25b

Y23

0.00 ± 0.00c

19.00 ± 0.61bc

14.00 ± 0.41c

20.67 ± 0.64b

0.00 ± 0.00e

24.00 ± 1.23b

0.00 ± 0.00c

20.00 ± 0.87b

16.33 ± 0.42b

06.33 ± 0.31d

Y33

11.67 ± 0.32a

24.33 ± 0.52a

21.00 ± 0.43a

28.00 ± 0.72a

25.00 ± 1.05a

28.00 ± 1.61a

22.00 ± 0.74a

27.67 ± 0.98a

18.67 ± 0.34a

12.33 ± 0.24a

Y41

0.00 ± 0.00c

20.67 ± 0.42b

11.67 ± 0.24d

0.00 ± 0.00d

13.67 ± 1.04d

0.00 ± 0.00e

14.33 ± 1.02b

0.00 ± 0.00d

11.67 ± 0.73d

0.00 ± 0.00e

  1. Erythromycin results based on R ≤ 13 mm; I: 13–23 mm; S ≥ 23 mm.
  2. Gentamycin results based on R ≤ 6 mm; I: 7–9 mm; S ≥ 10 mm.
  3. Vancomycin results based on R ≤ 12 mm; I: 12–13 mm; S ≥ 13 mm.
  4. I: intermediate (zone diameter, 12.5–17.4 mm); R: resistant (zone diameter, ≤ 12.4 mm); S: susceptible (zone diameter, ≥ 17.5).
  5. V vancomycin, S streptomycin, K kanamycin, TE tetracycline, E erythromycin, AM ampicillin, CC clindamycin, C chloramphenicol, CN cephalexin, GM gentamycin.
  6. *Values are mean ± standard error of triplicates.
  7. a–eMeans in the same row with different lowercase letters differed significantly (P < 0.05).